These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 9808685)

  • 1. How important are gender differences in pharmacokinetics?
    Meibohm B; Beierle I; Derendorf H
    Clin Pharmacokinet; 2002; 41(5):329-42. PubMed ID: 12036391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotransformation of tirilazad in human: 3. tirilazad A-ring reduction by human liver microsomal 5alpha-reductase type 1 and type 2.
    Wienkers LC; Steenwyk RC; Hauer MJ; Fleishaker JC; Pearson PG
    J Pharmacol Exp Ther; 1998 Nov; 287(2):583-90. PubMed ID: 9808684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of tirilazad in human: 2. Effect of ketoconazole on tirilazad clearance and oral bioavailability.
    Fleishaker JC; Pearson PG; Wienkers LC; Pearson LK; Peters GR
    J Pharmacol Exp Ther; 1996 May; 277(2):991-8. PubMed ID: 8627582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase.
    Wienkers LC; Steenwyk RC; Mizsak SA; Pearson PG
    Drug Metab Dispos; 1995 Mar; 23(3):383-92. PubMed ID: 7628305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender does not affect the degree of induction of tirilazad clearance by phenobarbital.
    Fleishaker JC; Pearson LK; Peters GR
    Eur J Clin Pharmacol; 1996; 50(1-2):139-45. PubMed ID: 8739825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of phenytoin on the pharmacokinetics of tirilazad mesylate in healthy male volunteers.
    Fleishaker JC; Hulst LK; Peters GR
    Clin Pharmacol Ther; 1994 Oct; 56(4):389-97. PubMed ID: 7955800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5alpha-reductase inhibitors/finasteride.
    Stoner E
    Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5 alpha-reductase inhibitors, chemical and clinical models.
    Guarna A; Occhiato EG; Danza G; Conti A; Serio M
    Steroids; 1998; 63(5-6):355-61. PubMed ID: 9618802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lazaroids. CNS pharmacology and current research.
    Clark WM; Hazel JS; Coull BM
    Drugs; 1995 Dec; 50(6):971-83. PubMed ID: 8612475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possibilities of brain protection with tirilazad after cardiac arrest.
    Sterz F; Janata K; Kürkciyan I; Müllner M; Malzer R; Schreiber W
    Semin Thromb Hemost; 1996; 22(1):105-12. PubMed ID: 8711485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of tirilazad in human: 4. effect of finasteride on tirilazad clearance and reduced metabolite formation.
    Fleishaker JC; Pearson PG; Wienkers LC; Pearson LK; Moore TA; Peters GR
    J Pharmacol Exp Ther; 1998 Nov; 287(2):591-7. PubMed ID: 9808685
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.